Use of psychiatric drugs in Dermatology,

Detalhes bibliográficos
Autor(a) principal: Weber,Magda Blessmann
Data de Publicação: 2020
Outros Autores: Recuero,Júlia Kanaan, Almeida,Camila Saraiva
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200133
Resumo: Abstract Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders.
id SBD-1_618e89bfc68c7e9f5882fdf4cb1b910f
oai_identifier_str oai:scielo:S0365-05962020000200133
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Use of psychiatric drugs in Dermatology,Antidepressive agentsDermatologyPsychopharmacologyPsychosomatic medicinePsychotropic drugsAbstract Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders.Sociedade Brasileira de Dermatologia2020-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200133Anais Brasileiros de Dermatologia v.95 n.2 2020reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1016/j.abd.2019.12.002info:eu-repo/semantics/openAccessWeber,Magda BlessmannRecuero,Júlia KanaanAlmeida,Camila Saraivaeng2020-07-03T00:00:00Zoai:scielo:S0365-05962020000200133Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2020-07-03T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Use of psychiatric drugs in Dermatology,
title Use of psychiatric drugs in Dermatology,
spellingShingle Use of psychiatric drugs in Dermatology,
Weber,Magda Blessmann
Antidepressive agents
Dermatology
Psychopharmacology
Psychosomatic medicine
Psychotropic drugs
title_short Use of psychiatric drugs in Dermatology,
title_full Use of psychiatric drugs in Dermatology,
title_fullStr Use of psychiatric drugs in Dermatology,
title_full_unstemmed Use of psychiatric drugs in Dermatology,
title_sort Use of psychiatric drugs in Dermatology,
author Weber,Magda Blessmann
author_facet Weber,Magda Blessmann
Recuero,Júlia Kanaan
Almeida,Camila Saraiva
author_role author
author2 Recuero,Júlia Kanaan
Almeida,Camila Saraiva
author2_role author
author
dc.contributor.author.fl_str_mv Weber,Magda Blessmann
Recuero,Júlia Kanaan
Almeida,Camila Saraiva
dc.subject.por.fl_str_mv Antidepressive agents
Dermatology
Psychopharmacology
Psychosomatic medicine
Psychotropic drugs
topic Antidepressive agents
Dermatology
Psychopharmacology
Psychosomatic medicine
Psychotropic drugs
description Abstract Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the most suitable treatment rapidly. It is important for dermatologists to be familiar with the most commonly used drugs for the best management of psychiatric symptoms associated with dermatoses, as well as to manage dermatologic symptoms triggered by psychiatric disorders.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200133
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200133
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.abd.2019.12.002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.95 n.2 2020
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126423818043392